Medicare Enrolled
Dr. Antoine Harb, MD
Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harb?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harb
Dr. Antoine Harb is a hematology & oncology specialist in San Antonio, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Harb performed 48,680 Medicare services across 1,834 unique beneficiaries.
Between the years covered by Open Payments, Dr. Harb received a total of $7,994 from 66 pharmaceutical and/or device companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harb is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 20% volume in TX
$7,994 industry payments
Medicare Practice Summary
Medicare Utilization ↗48,680
Medicare services
Top 20% in TX for hematology & oncology
1,834
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,864 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
42,250 | $1 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,012 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
619 | $8 | $23 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
616 | $10 | $32 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
494 | $8 | $16 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
395 | $129 | $523 |
| Anti-nausea injection (ondansetron/Zofran) | 360 | $0 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
261 | $22 | $86 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
194 | $93 | $349 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
168 | $49 | $185 |
| Iron level test | 161 | $6 | $19 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
161 | $9 | $26 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
161 | $99 | $377 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
159 | $13 | $41 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
157 | $6 | $18 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
143 | $4 | $14 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
136 | $12 | $58 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
134 | $94 | $380 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
133 | $6 | $19 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
133 | $11 | $47 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
89 | $9 | $28 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
80 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
79 | $22 | $90 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
71 | $1 | $1 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
64 | $16 | $60 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
63 | $19 | $57 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
54 | $2 | $19 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 48 | $20 | $62 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 48 | $358 | $1,371 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
44 | $10 | $42 |
| New patient office visit, complex (60-74 min) | 43 | $156 | $641 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
32 | $15 | $45 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
29 | $24 | $137 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
28 | $7 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $68 | $311 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $136 | $589 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $53 | $263 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
88.3% high complexity
3.8% medium
7.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,994
Total received (2018-2024)
Avg $1,599/year across 5 years
Top 36% in TX for hematology & oncology
66
Companies
351
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,893 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$102 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,668
2023
$2,086
2022
$1,597
2021
$525
2018
$119
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$872
E.R. Squibb & Sons, L.L.C.
$559
Merck Sharp & Dohme LLC
$499
AstraZeneca Pharmaceuticals LP
$456
GENZYME CORPORATION
$366
Karyopharm Therapeutics Inc.
$363
Daiichi Sankyo Inc.
$338
Amgen Inc.
$295
Incyte Corporation
$280
Celgene Corporation
$251
Genentech USA, Inc.
$238
Tempus AI, Inc
$236
GlaxoSmithKline, LLC.
$230
Takeda Pharmaceuticals U.S.A., Inc.
$158
Bayer HealthCare Pharmaceuticals Inc.
$158
Lilly USA, LLC
$154
Alexion Pharmaceuticals, Inc.
$147
Bayer Healthcare Pharmaceuticals Inc.
$143
Janssen Biotech, Inc.
$119
Genmab U.S., Inc.
$118
Adaptive Biotechnologies Corporation
$114
PFIZER INC.
$114
Kite Pharma, Inc.
$114
Merck Sharp & Dohme Corporation
$97
TAIHO ONCOLOGY, INC.
$97
ADC Therapeutics America, Inc.
$84
Deciphera Pharmaceuticals Inc.
$79
MorphoSys, US Inc.
$74
Rigel Pharmaceuticals, Inc.
$71
Eisai Inc.
$69
Regeneron Healthcare Solutions, Inc.
$68
Agios Pharmaceuticals, Inc.
$57
Astellas Pharma US Inc
$57
Sandoz Inc.
$56
SERVIER PHARMACEUTICALS LLC
$54
Sobi, Inc
$48
Stemline Therapeutics Inc.
$45
ABBVIE INC.
$44
PharmaEssentia USA Corporation
$44
Ipsen Biopharmaceuticals, Inc
$39
Gilead Sciences, Inc.
$35
Pharmacosmos Therapeutics Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Mirati Therapeutics, Inc.
$33
Immunocore Limited
$33
Apellis Pharmaceuticals, Inc.
$28
Foundation Medicine, Inc.
$26
CTI BioPharma Corp.
$24
SOBI, INC
$23
EISAI INC.
$22
Sirtex Medical Inc
$21
Spectrum Pharmaceuticals Inc.
$21
Pharmacyclics LLC, An AbbVie Company
$20
RECORDATI_RARE_DISEASES_INC.
$20
JAZZ PHARMACEUTICALS INC.
$20
Dova Pharmaceuticals
$20
Octapharma USA, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$20
SpringWorks Therapeutics, Inc.
$20
AMAG Pharmaceuticals, Inc.
$19
EMD Serono, Inc.
$19
Alnylam Pharmaceuticals Inc.
$17
Seagen Inc.
$17
Exelixis Inc.
$15
Blueprint Medicines Corporation
$14
Azurity Pharmaceuticals, Inc.
$13
Top 3 companies account for 24.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AUGTYRO · AYVAKIT · Adempas · BESREMI · BLENREP · BOSULIF · CABLIVI · CABOMETYX · CALQUENCE · Columvi · DOPTELET · Doptelet · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FERAHEME · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · IBRANCE · ICLUSIG · IMBRUVICA · INJECTAFER · JAKAFI · JEVTANA · Jivi · KEYTRUDA · KIMMTRAK · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PANZYGA · PLUVICTO · PROMACTA · PYRUKYND · Pomalyst · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SYLVANT · Stivarga · TAGRISSO · TASIGNA · TECVAYLI · TIBSOVO · TIVDAK · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VIVIMUSTA · VPRIV · Venclexta · Vonjo · Vyloy · XGEVA · XPOVIO · Xospata · Yescarta · ZEJULA · ZEPZELCA · ZIEXTENZO · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $16 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
56
Per 100K population
2.7
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Harb is a mixed practice specialist, with above-average Medicare volume (top 20% in TX), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Harb experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Harb performed 42,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harb receive payments from pharmaceutical companies?
Yes. Dr. Harb received a total of $7,994 from 66 companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harb's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Harb's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Antonio
Browse hematology & oncology specialists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology